Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan
· Delayed Price · Currency is TWD 36.60
-0.05 (-0.14%)
Jun 20, 2025, 1:30 PM CST
Tien Liang BioTech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 18, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 1,677 | 1,899 | 664 | 707 | 677 | 513 | Upgrade
|
| Market Cap Growth | 27.80% | 186.21% | -6.15% | 4.39% | 32.14% | 18.77% | Upgrade
|
| Enterprise Value | 1,955 | 1,835 | 619 | 721 | 727 | 578 | Upgrade
|
| Last Close Price | 36.65 | 41.50 | 14.30 | 15.23 | 14.59 | 11.04 | Upgrade
|
| PE Ratio | 77.06 | 162.37 | 37.42 | 11.89 | 14.53 | - | Upgrade
|
| Forward PE | - | 10.79 | 10.79 | 10.79 | 10.79 | 10.79 | Upgrade
|
| PS Ratio | 4.37 | 4.93 | 1.44 | 1.34 | 1.19 | 1.19 | Upgrade
|
| PB Ratio | 3.37 | 3.97 | 1.35 | 1.49 | 1.64 | 1.40 | Upgrade
|
| P/TBV Ratio | 3.37 | 3.98 | 1.35 | 1.49 | 1.64 | 1.40 | Upgrade
|
| P/FCF Ratio | 42.68 | 42.87 | 10.25 | 33.88 | 15.18 | - | Upgrade
|
| P/OCF Ratio | 37.93 | 39.28 | 9.52 | 32.31 | 14.98 | - | Upgrade
|
| EV/Sales Ratio | 5.09 | 4.76 | 1.35 | 1.37 | 1.27 | 1.34 | Upgrade
|
| EV/EBITDA Ratio | 181.56 | 198.41 | 21.48 | 10.56 | 13.43 | - | Upgrade
|
| EV/EBIT Ratio | - | 3094.22 | 32.79 | 12.37 | 16.93 | - | Upgrade
|
| EV/FCF Ratio | 49.76 | 41.42 | 9.57 | 34.56 | 16.30 | - | Upgrade
|
| Debt / Equity Ratio | 0.91 | 0.70 | 0.14 | 0.21 | 0.32 | 0.47 | Upgrade
|
| Debt / EBITDA Ratio | 42.27 | 34.42 | 2.42 | 1.47 | 2.42 | - | Upgrade
|
| Debt / FCF Ratio | 11.59 | 7.57 | 1.10 | 4.86 | 2.97 | - | Upgrade
|
| Asset Turnover | 0.45 | 0.50 | 0.69 | 0.79 | 0.89 | 0.68 | Upgrade
|
| Inventory Turnover | 2.36 | 2.31 | 2.04 | 2.46 | 4.11 | 3.25 | Upgrade
|
| Quick Ratio | 0.38 | 0.42 | 1.50 | 1.11 | 0.97 | 0.76 | Upgrade
|
| Current Ratio | 0.57 | 0.61 | 2.13 | 1.76 | 1.32 | 1.04 | Upgrade
|
| Return on Equity (ROE) | 4.36% | 2.41% | 3.66% | 13.38% | 11.93% | -13.13% | Upgrade
|
| Return on Assets (ROA) | 0.12% | 0.05% | 1.77% | 5.47% | 4.19% | -4.97% | Upgrade
|
| Return on Capital (ROIC) | 0.13% | 0.05% | 2.07% | 6.49% | 4.94% | -5.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.30% | 0.10% | 3.70% | 11.90% | 10.00% | - | Upgrade
|
| Earnings Yield | 1.30% | 0.62% | 2.67% | 8.41% | 6.88% | -10.08% | Upgrade
|
| FCF Yield | 2.34% | 2.33% | 9.75% | 2.95% | 6.59% | -2.33% | Upgrade
|
| Dividend Yield | 1.36% | - | 3.50% | - | - | - | Upgrade
|
| Payout Ratio | 105.13% | 195.62% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 0.04% | 0.04% | -0.01% | -0.05% | - | - | Upgrade
|
| Total Shareholder Return | 1.39% | 0.04% | 3.49% | -0.05% | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.